chrisvoncsefalvay/vaers-outcomes huggingface dataset:
7 hours post vaccine my son indicated site was hurting, I disregarded as regular response to IM vaccine. 16 hours post vaccine the site had red blush and he was saying it hurt to move his arm, still appeared within expected mild response according to hand out from clinic, I sent him to school. By the time I saw him at 28 hours post vaccine the site had become hot, deep pink swelling wrapped around upper arm into the arm pit, reported to be pruritic and painful. Two small blister hives were present, due to continued progression had to go to emergency room.
At 11:35 gave varicella on the LLT. 10 minutes later while mother was breastfeeding him, mother noticed a small bump with redness on the LLT where vaccine was given. Dr took look at the pt., recommended ice pack and have mother and pt wait few minutes to observe. 12 noon bump was gone. Mother instructed to notify private pediatrician.
is finger numbness a side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (is finger numbness a side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (is finger numbness a side effect). At the time of the report, HYPOAESTHESIA (is finger numbness a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was provided. No treatment medication details was provided.   Reporter did not allow further contact
I usually experience mild side effects from vaccines. I experienced all listed common side effects; however, I am reporting that pain/ache in my arthritic hands were unusually severe, more than the joints of the rest of my body. All has subsided within 48 hours
Pt developed immediate rash and pruritis after vaccine. Treated with ice pack in clinic. Limping with leg pain next morning 5/4/06. Developed fever T 102F pm of 5/4/06. Admitted 5/5/06 15:15 pm for increased swelling and pain for cellulitis vs 2" rxn to vaccine. Treated with Clindamycin - discharged 5/8/06. 10/12/06 Received medical records from hospital which reveal patient admitted to hospital 5/5/06-5/8/06 s/D/C dx: RLE cellulitis, sinusitis & history of hypogammaglobulinemia, asthma & chronic URI, bronchitis/pneumonia & sinus infections.  Presented with being unable to walk on right leg secondary to symptoms.  S/S slowly resolved with IV antibiotics.  D/C to home on oral antibiotics for another 2 weeks/ss
Case previously recorded as MA2009-4214. Initial case report received from a nurse, via Novartis Medical Communication on 11 NOV 2009. A patient under 4 year-old was vaccinated with 0.25 ml of S-OIV FLUVIRIN (batch no. 102046P1) i.m., on 10 NOV 2009. No adverse event was reported. MedCom reference no.: NA09-008010.
PATIENT SAYS ABOUT 3 MONTHS AFTER GETTING THE PNEMOVAX 23 VACCINE HE HAS HAD PAIN IN HIS LEFT ARM STARTING BACK BEHIND THE ARMPIT AND RADIATING DOWN TO ABOUT THE ELBOW. THERE DOESN'T APPEAR TO BE ANY SWELLING AT THE MOMENT. HE SAYS THE PAIN IS RELIEVED WITH OTC PAIN RELIEVERS BUT IT JUST COMES BACK. HE ALSO GOT A FLU SHOT AT THE SAME TIME.  SAYS HE HASN'T HAD THIS KIND OF REACTION TO THE FLU SHOT BEFORE
Flu and cold symptoms with conjunctivitis in both eyes. Symptoms included fever of up to 99.7 degrees Fahrenheit, muscle aches, nausea, sore throat, cough, sinus congestion, sneezing.
Allergic reaction versus syncope episode. Hive rash, prickly heat bilateral arms chest legs and feet. 40 mg Benadryl injection with epi pen preacribed incase of anaphylaxis. Bendaryl 50 mg tablet to be taken q4-6 prn. Low grade fever 99.8 1 day after injection.
Pt stated that was very sore on 9-3-09 (day after administration). The muscle under the site of injection on (L) arm is the size of a baseball with swelling, hot to touch. Denies SOB. Advised to use ice to help ease any discomfort. PT states she cannot take BENADRYL because she has had problems with that medication in the past.
mom relates for 24 hrs following vax had t105.6; down 101 was seen in ER not adm, no sz progressively improved during 2nd 24 hrs;
Feeling sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 3 days after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   The reporter considered the sickness to be probably related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient's spouse. The age at vaccination was not reported. The patient received 1st dose shingles and experienced feeling felt sick. The reporter stated that it was probably due to shingrix vaccine, The information regarding consent to follow up was not reported.
She got her vaccine, and about 2 weeks later started noticing raised rash/bumps in a semi-circle ring pattern under both of her arms.  She was diagnosed after a biopsy as having granuloma annulare, and given Clobetasol ointment for that reaction.  The name of the dermatologic clinic was (clinic name).  Doctor did the biopsy. She then followed up with another doctor whom she saw today.  They discussed that it may be due to the vaccine, he stated that there has been reactions like hers due to the vaccine.  He was a pathologist at one point, and now practices dermatology.   The clinic was in state.    Her 2nd vaccine was on 2/12/21, Pfizer, lot #EL9269.    She received the booster on 9/21/21, lot #FF2588
Soreness,hot,tender to touch, radiates down the arm,tender to lay on or touch,muscle weakness
Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-SEP-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 2.5 ml/five dose vial, lot # K007773 and expiration date 01-MAY-2015 (administration route was not provided). No adverse effects were reported. The vaccine had one temperature excursion of 48 hours with a lowest recorded temperature of 1 Fahrenheit (F) (1 Celsius (C)). The storage criteria and the type of excursion for this vaccine was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Flu-like symptoms reported as- nauseous, chills, aches for 24 hour duration. Patient also reported a low temperature of 94 degrees.
Received H1N1(killed) vaccine. 11/5/09 at 5:30pm waited in bldg after shot for 20 min. Felt a little dizzy but didn't tell anyone as had been a stressful day for her woke up with red pruritic rash on face, neck, back and abdomen. Saw nurse at hospital today given atarax and Medrol dose pak for rash, dizziness, tachy cardia and released home11-6-09.
Reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reactions) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reactions). At the time of the report, VACCINATION COMPLICATION (Reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No  Concomitant medications were provided. No Treatment medications were provided.
Hives w/swelling of face & hands; treated in ER w/Epi & steroids & givenscript for DPH & Medrol dose pack; resolving;
He awoke from falling asleep after the shot and was inconsolable. He wouldn't eat or nurse. He began making body jerking movements and would have a stunned look on his face as his eyes would roll back in his head and his back would arch and his arms and legs stiffened straight. We thought he was throwing a fit from discomfort. This continued for about 72 hours. He never nursed again and cried every time I tried. We had no idea these were seizures and were told that 'if they were...you would know'?. From then on, he had what we thought were long periods of 'daydreaming' episodes that would last long enough that he would fall to one side. Upon going for his next checkup, the Pediatrician noticed his daydreaming during our visit and asked if he did that a lot. She then referred us to a Neurologist. Patient underwent an MRI and many other tests and he was diagnosed with Complex partial seizures due to encephalopathy. He still suffers from recurrent seizure activity and is medicated and homeschooled.
No Adverse Event; primary series of Moderna COVID19 Vaccine expired on 25Nov2022 but it was administered 8Dec2022.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (primary series of Moderna COVID19 Vaccine expired on 25Nov2022 but it was administered 8Dec2022.) and NO ADVERSE EVENT (No Adverse Event) in a 30-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 054B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Dec-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 08-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (primary series of Moderna COVID19 Vaccine expired on 25Nov2022 but it was administered 8Dec2022.). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (primary series of Moderna COVID19 Vaccine expired on 25Nov2022 but it was administered 8Dec2022.) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (primary series of Moderna COVID19 Vaccine expired on 25Nov2022 but it was administered 8Dec2022.).    No concomitant drug information was provided.  It was confirmed that there was no parental exposure. It was reported that the patient had not received any other vaccine in 4 weeks prior to COVID-19 vaccine. The reporter didn't knew if the patient had experienced any adverse event since the patient was not contacted.  No treatment drug information was provided.
patient found on floor in home on 12/20/21 and passed away on 1/12/22.  Longtime friend, is the person reporting this as an adverse event.
PRESENTED 7 DAYS POST INJECTION COMPLAINING MYLAGIAS, ARTHRALGIAS, HEADACHE AND PHOTOPHOBIA.  INITIALLY HAD A LOCAL REACTION OF INJECTION SITE PAIN, THEN STARTED WITH BODY ACHES AND HEADACHE.  DENIED NAUSEA, VOMITING. C/O MENTAL FOG. NO FOCAL NEURO DEFICIT.
Patient reported that she had been severely lethargic since the day after her shot and that the arm in which she received her SHINGRIX shot was very swollen and hot. Her husband, an ER nurse, suspected cellulitis and she sought treatment at his facility. The provider on staff at the ER concurred and prescribed Bactrim DS bid  for 7 days.
devel lesions 13APR99 afebrile 10-12, body lesions scattered;
Flu shot given at approx. 11:10. At 11:50, noticed nose, then eyes and then mouth began to itch. Notified pt's MD. Benadryl 50mg, IM, given at 12:45. Mouth still itched at 13:30. Taker to ER for evaluation and discharged. On 11/7/02, client back to work on 11/6/02.
head to toe rash 21 days post vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (head to toe rash 21 days post vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (head to toe rash 21 days post vaccine). At the time of the report, RASH (head to toe rash 21 days post vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medications and treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Non significant follow up is added Contains NNI
I just had a sore throat, muscle aches, runny nose, sneezing. My fever got to 101.2. This lasted for about 2 days. It definitely was not severe. I feel much better today.
HEADACHE; CHILLS; SWEATING; HEART RACING; FELT HOT; MUSCLE PAINS; This spontaneous report received from a consumer concerned a 19 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, expiry: 25/MAY/2021) dose was not reported, administered on 15-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 15-MAR-2021, the subject experienced headache. On 15-MAR-2021, the subject experienced chills. On 15-MAR-2021, the subject experienced sweating. On 15-MAR-2021, the subject experienced heart racing. On 15-MAR-2021, the subject experienced felt hot. On 15-MAR-2021, the subject experienced muscle pains. Treatment medications (dates unspecified) included: oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt hot, and muscle pains, and was recovering from headache, chills, sweating, and heart racing. This report was non-serious.
Severe joint pain throughout body.  Severe pain, swelling and water blistering at injection site.  Swollen/red area 5 inch diameter surrounding injection site.  Fever 102.4 F.
headache pain score 7 out of 10 and chills over 1.5 hours after receiving vaccine.
Began a heavy menstrual cycle within 3 weeks of last injection. Heavier than normal, unable to participate in normal activities due to flow. This lasted 6 weeks. The flow then held a schedule of on for 3 days and off for 7 for the next 3 weeks. After that the flow stopped entirely. I have been amenorrhea since August 2021, Within months of receiving my vaccine I went from having a normal menstrual cycle to being menopausal.
Caller states he had second dose of vaccine yesterday at 1:30 pm. Around 5:00 pm on yesterday, developed vomiting, fever of 101.0 and extreme stomach pain. Caller also states he drank milk and took 400 mg of Ibuprofen on an empty stomach. Informed to not take Ibuprofen with milk or on an empty stomach. Also to retake temp and if it remains elevated to contact his PCP. Also encourage to apply cold compresses to arm and observe for swelling or increase pain.
Got 1st dose Oct2021, currently has shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th October 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received dose of Shingrix vaccine and experienced shingles. No other details of patient or vaccine were provided. The reporter consented to follow-up.
Was tired; Was not hungry; Was sweating; Head hurt; Ear hurt; Could not fall asleep the night of receiving the second vaccine; Arm hurt so badly/ arm hurt again; Chills; This is a spontaneous report from a contactable nurse. An adult female patient of an unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 18Apr2021 at 12:30 as a single dose for COVID-19 immunisation. The patients' medical history was not reported. It was unknown whether the patient was pregnant at the time of vaccination. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications included unspecified antibiotics taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 28Mar2021 at 12:30 as a single dose for COVID-19 immunisation. It was unknown whether the patient received any other vaccines within four weeks prior to the COVID-19 vaccination. On 18Apr2021, the patient could not fall asleep the night of receiving the second vaccine, her arm hurt so badly and she had chills. On 19Apr2021, in the morning of the day after she received the vaccine, her arm was better, but not the chills, she was tired and was not hungry. On 19Apr2021, in the afternoon of the day after she received the vaccine, the patient was tired, remained with chills all day and was sweating, her head and ear hurt and arm hurt again. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events could not fall asleep the night, arm hurt so badly, chills, tired, not hungry, sweating, head hurt, ear hurt and arm hurt again was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
After receiving the 1st dose of The Pfizer vaccine, I was caring for my mother at the time and started to feel very different. I decided to take my blood pressure and it read 240/128. I contacted the paramedics and was admitted to the hospital for a 24-hour observation. After 2 weeks I then had to be admitted again to the hospital after my blood pressure dropped to low. A full cardiac workup was performed and found no abnormalities. To this day my heart rate is still high.
Fevers to 103 Rigors for 3-4 hours Headache the next day Fatigue Diarrhea/abdominal pain Shortness of breath x 3 weeks now.
COVID-19 symptoms started on 07/24/22; tested positive on 07/25/2022. It started with a strange taste or smell and I was starting to feel congestion in my throat but I didn't really feel sick. I did a test and it was negative, but then later that day I felt achy and more tired and at night I got bad indigestion and threw up twice and had diarrhea. The next morning I felt terrible as far as achiness and upset stomach and not wanting to eat anything. I did another test and it was positive and I decided at that point to call my doctor to try and get PAXLOVID. I had a telehealth appointment on Tuesday morning and throughout that day I had bad indigestion and achiness and I took some TYLENOL a few times during the day for that and I talked to doctor and the next morning I got a prescription for PAXLOVID and started that 07/26 and my symptoms have gotten better but I still feel tired and achy but no problems with stomach.
This case was reported by a physician and described the occurrence of accidental overdose in a 25-month-old female subject who was vaccinated with HAVRIX (GlaxoSmithKline). On 13 February 2014 at 13:30 the subject received unspecified dose of HAVRIX (1 ml, unknown) and experienced accidental overdose and inappropriate age at vaccine administration. The subject accidentally received an adult dose (1.0mL) of HAVRIX. At the time of the report no other information was provided. The HAVRIX recommendation for children and adolescents is 0.5mL dose and 0.5mL booster dose administered between six to 12 months later. Follow-up information was received on 04 March 2014 via physician. Concurrent vaccination included seasonal influenza vaccine (non-gsk); non-GSK manufacturer; intramuscular; unknown given on an unspecified date; details not provided. The physician reported the subject developed hives at site of administration later that evening. 13 February 2014 and resolved without the use of medication on 14 February 2014. The physician considered the events were probably related to vaccination with HAVRIX. The physician attributed the events to erroneous administration of HAVRIX. No action was taken with HAVRIX. Children and adolescents (12 months through 18 years of age) are recommended to receive HAVRIX 0.5mL dose and 0.5mL booster dose administered anytime between six and 12 months later.
Breakthrough covid infection. Patient tested positive on July 6 2021. Patient fully vaccinated Feb 3, 2021.
The next day, my arm was sore, had a low grade fever all day, vomiting in the morning, tired, slight headache and body aches.